Financhill
Sell
18

CASI Quote, Financials, Valuation and Earnings

Last price:
$2.65
Seasonality move :
4.5%
Day range:
$2.65 - $2.82
52-week range:
$2.05 - $8.19
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.67x
P/B ratio:
2.96x
Volume:
76.9K
Avg. volume:
45.4K
1-year change:
-59.17%
Market cap:
$41M
Revenue:
$33.9M
EPS (TTM):
-$2.24

Earnings Data

Next earnings date for CASI
Mar 28
2025
Most recent earnings per share
-$0.55
Missed by $0.55
(Nov 14/2024)
Consensus Estimate
--
(Nov 14/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CASI Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/28/2025 Q4 $7.4M -- -- -- --
11/14/2024 Q3 $4.6M $7.8M -$0.55 -- --
08/20/2024 Q2 $4.4M $4M -$0.52 -- --
05/20/2024 Q1 $12M $3.4M -$0.71 -- --
03/28/2024 Q4 $9.4M $6.9M -$0.46 -$0.24 -$0.22
11/01/2023 Q3 -- -- -$0.35 -- --
08/01/2023 Q2 -- -- -$0.77 -$0.50 -$0.27
03/31/2023 Q1 -- -- -$0.45 -- --
03/28/2023 Q4 -- -- -$1.44 -- --
11/11/2022 Q3 -- -- -$0.38 -$0.38 --
08/12/2022 Q2 -- -- -$0.56 -$0.61 $0.05
05/12/2022 Q1 -- -- -$0.62 -- --
03/28/2022 Q4 -- -- -$0.39 -- --
11/12/2021 Q3 -- -- -$0.73 -- --
08/12/2021 Q2 -- -- -$0.50 -- --
05/13/2021 Q1 -- -- -$1.10 -- --
03/30/2021 Q4 -- -- -$1.17 -- --
11/09/2020 Q3 -- -- -$1.40 -- --
08/10/2020 Q2 -- -- -$0.90 -- --
05/11/2020 Q1 -- -- -$0.90 -- --
03/16/2020 Q4 -- -- -$1.30 -- --
11/12/2019 Q3 -- -- -$1.00 -- --
08/09/2019 Q2 -- -- -$1.60 -- --
05/15/2019 Q1 -- -- -$0.90 -- --
03/29/2019 Q4 -- -- -$1.00 -- --
11/14/2018 Q3 -- -- -$1.00 -- --
08/14/2018 Q2 -- -- -$0.70 -- --
05/15/2018 Q1 -- -- -$0.50 -- --
03/29/2018 Q4 -- -- -$0.80 -- --
11/14/2017 Q3 -- -- -$0.30 -- --
08/14/2017 Q2 -- -- -$0.40 -- --
03/31/2017 Q1 -- -- -$0.30 -- --
03/31/2017 Q4 -- -- -$0.44 -- --
11/14/2016 Q3 -- -- -$0.30 -- --
08/15/2016 Q2 -- -- -$0.80 -- --
05/13/2016 Q1 -- -- -$0.40 -- --
03/28/2016 Q4 -- -- -$0.50 -- --
11/13/2015 Q3 -- -- -$0.50 -- --
08/14/2015 Q2 -- -- -$0.60 -- --
05/15/2015 Q1 -- -- -$0.60 -- --
03/27/2015 Q4 -- -- -$0.20 -- --

CASI Pharmaceuticals Earnings Questions

  • How Much did CASI Pharmaceuticals Generate in Revenue Last Quarter?

    CASI Pharmaceuticals reported $7.8M worth of top line sales in its most recent quarter.

  • Did CASI Pharmaceuticals Beat Earnings Last Quarter?

    CASI Pharmaceuticals announced earnings per share of -$0.55 which represents a miss of analyst forecast a -- per share.

  • Is CASI Pharmaceuticals Profitable?

    CASI Pharmaceuticals reported $4M that represents $0.26 per share over the last quarter.

  • What is the Analyst Consensus for CASI Pharmaceuticals EPS Next Year?

    CASI Pharmaceuticals's earnings are forecast to decrease from -$2.02 per share to -$1.93 per share next year representing a decrease of -35.88%.

  • When is CASI Pharmaceuticals's Earnings Date?

    CASI Pharmaceuticals's next earnings date is March 28, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock